Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Psychiatry/Psychology
Search Medical Condition
Psychosis Clinical Trials
A listing of Psychosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (1094) clinical trials
XanADu: A Phase II, Double-Blind, 12-Week, Randomised, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to Alzheimer's Disease (AD).
This is a Phase II, randomised, multi-centre, double-blind, placebo-controlled proof-of-concept study to assess the safety, tolerability and efficacy of oral Xanamem™ once daily in adult subjects with mild dementia due to AD.
Risk Reduction for Alzheimer's Disease
The rrAD study is testing several strategies that may reduce the risk of Alzheimer’s disease in individuals at risk for the disease when compared to usual care. These strategies include: Aerobic exercise Intensive medical management of blood pressure and cholesterol The combination of these two approaches
GN39763: A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY, AND SAFETY STUDY OF MTAU9937A IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE
Research Study for Prodromal to Mild Alzheimer's Disease.
I5T-MC-AACG TRAILBLAZER-ALZ Assessment of Safety, Tolerability and Efficacy of LY3002813 Alone and in Combination With LY3202626 in Early Symptomatic Alzheimer’s Disease
This is a study for early to mild Alzheimer’s, testing the safety of LY3002813 with or without LY3202626 and any side effects from the study medicine. This study is also evaluating whether LY3002813 with or without LY3202626 can help slow the mental and functional changes of Alzheimer’s disease.
A Double-Blind, Placebo-Controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating The Efficacy, Safety, And Tolerability Of Cariprazine In A Dose-Reduction Paradigm In The Prevention Of Relapse In Bipolar I Disorder Patients Whose Current Episode Is Manic Or Depressive With Or Without Mixed Features
The purpose of this study is to look into the safety and efficacy of cariprazine in the treatment of Bipolar I disorder. Cariprazine is approved by the U.S. Food and Drug Administration (FDA) and currently licensed in the USA for the acute treatment of manic or mixed episodes associated with bipolar ...
A Washington University research study seeks participants, 35 – 80 years old.
The purpose of this research study is to learn about normal brain function and brain function in various stages of Alzheimer’s disease. There will be 1 baseline visit that will take approximately 7 hours and 1 optional follow up visit (2.5 to 3 years later). Study procedures include PET scans, ...
Teenage Major Depressive Disorder
Clinical Trials of Texas, Inc. is conducting a research study of an investigational medication for major depressive disorder in teenagers. Qualified participants receive study-related medical care from a board-certified physician, exams and evaluations.
Study of a new medication for the treatment of Alzheimer's Disease
The objective of this study is to assess the safety and tolerability of the study drug given orally twice daily for 28 days. The study will also assess the effects of study drug on oral and cerebrospinal fluid biomarkers. The study evaluations include 2 detailed dental examinations and 2 lumbar ...
Alzheimer's?
ActivMed Practices and Research is looking for volunteers to participate in a device research study on Alzheimer's Disease and memory loss.
Memory Loss Clinical Research Study
Participate in a clinical trial exploring memory loss at ActivMed Practices and Research, Inc. in Methuen, MA.
